HIV-1 Clinical Trials

57 recruitingLast updated: June 18, 2026

There are 57 actively recruiting hiv-1 clinical trials across 39 countries. Studies span Phase 2, Phase 1, Not Applicable, Phase 3, Phase 4, Early Phase 1. Top locations include Atlanta, Georgia, United States, San Francisco, California, United States, Los Angeles, California, United States. Updated daily from ClinicalTrials.gov.


HIV-1 Trials at a Glance

57 actively recruiting trials for hiv-1 are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Phase 2 with 18 trials, with the heaviest enrollment activity in Atlanta, San Francisco, and Los Angeles. Lead sponsors running hiv-1 studies include Gilead Sciences, National Institute of Allergy and Infectious Diseases (NIAID), and Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Treatments under study

About HIV-1 Clinical Trials

Looking for clinical trials for HIV-1? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV-1 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV-1 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 57 trials

Recruiting

Impacts of HIV Treatment Regimens on Archived Drug Resistance

HIV-1-infectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong420 enrolled1 locationNCT07643948
Recruiting

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Human Immunodeficiency Virus (HIV) -1 infectionHIV-1 Subtype A6 InfectionHIV-1 Subtype B Infection+1 more
Pomeranian Medical University Szczecin250 enrolled7 locationsNCT07370649
Recruiting
Phase 4

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection
Gilead Sciences350 enrolled15 locationsNCT06337032
Recruiting
Phase 1Phase 2

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Phase 2Phase 3

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled56 locationsNCT07266831
Recruiting
Phase 1

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

HIV-1
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled17 locationsNCT06517693
Recruiting
Phase 1Phase 2

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)90 enrolled12 locationsNCT05660980
Recruiting
Phase 2

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

FrailtyAgingHIV-1-infection+2 more
Massachusetts General Hospital100 enrolled2 locationsNCT06554717
Recruiting
Phase 1

Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)

HIV-1
Thomas Aagaard Rasmussen38 enrolled2 locationsNCT07481175
Recruiting
Not Applicable

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

hepatitis B infectionHIV-1-infectionSyphilis Infection+1 more
bioLytical Laboratories1,000 enrolled3 locationsNCT07563309
Recruiting
Not Applicable

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

ObesityHIV-1-infection
University College Dublin80 enrolled1 locationNCT04174755
Recruiting
Early Phase 1

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

HIV-1-infection
University of California, San Diego138 enrolled1 locationNCT04883255
Recruiting
Phase 2

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

HIV-1-infection
Gilead Sciences12 enrolled9 locationsNCT06749054
Recruiting
Phase 2

HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study

HIV-1-infection
TaiMed Biologics Inc.75 enrolled10 locationsNCT07215468
Recruiting

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

HIV-1-infectionPregnancy RelatedBreastfeeding
International Maternal Pediatric Adolescent AIDS Clinical Trials Group1,150 enrolled11 locationsNCT07293559
Recruiting
Phase 1

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

HIV-1-infection
BioNTech SE61 enrolled3 locationsNCT07392372
Recruiting
Not Applicable

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

HIV InfectionHIVStigma+3 more
Casper Rokx5,200 enrolled28 locationsNCT06900829
Recruiting
Phase 2

A Clinical Trial of STP0404 in Adults With HIV-1 Infection

HIV-1-infection
ST Pharm Co., Ltd.36 enrolled13 locationsNCT05869643
Recruiting
Phase 1

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

HIV-1-infection
Gilead Sciences16 enrolled7 locationsNCT07055451
Recruiting
Phase 1

Study of GS-3242 in Participants With HIV-1; Substudy-05

HIV-1-infection
Gilead Sciences30 enrolled28 locationsNCT07001319